4//SEC Filing
AYCARDI-FONSECA ERNESTO 4
Accession 0001209191-19-050127
CIK 0001582313other
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 6:21 PM ET
Size
5.2 KB
Accession
0001209191-19-050127
Insider Transaction Report
Form 4
AYCARDI-FONSECA ERNESTO
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-09-16+65,000→ 65,000 totalExercise: $9.44Exp: 2029-09-15→ Common Shares (65,000 underlying)
Footnotes (1)
- [F1]Vesting over 36 months, in equal amounts, on the last day of each month.
Documents
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeother
Related Parties
1- filerCIK 0001734218
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 6:21 PM ET
- Size
- 5.2 KB